Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19256777 | OCEANOBACILLUS JEDDAHENSE STRAIN HMF12 AND ITS APPLICATION | July 2025 | December 2025 | Allow | 6 | 1 | 0 | Yes | No |
| 19223085 | METHOD FOR SEPARATING AMOXICILLIN AND PHENYLACETIC ACID FROM REACTION SOLUTION IN ONE-STEP ENZYMATIC SYNTHESIS OF AMOXICILLIN | May 2025 | July 2025 | Allow | 2 | 0 | 0 | Yes | No |
| 19189316 | ONE-STEP METHOD FOR SYNTHESIZING AMOXICILLIN FROM PENICILLIN OR SALT THEREOF THROUGH ENZYME CATALYSIS | April 2025 | September 2025 | Allow | 5 | 1 | 1 | No | No |
| 19180258 | APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS | April 2025 | December 2025 | Abandon | 8 | 1 | 1 | No | No |
| 19048619 | USE OF PLATELET-BASED PRODUCTS FOR TREATMENT OF CAPSULAR CONTRACTURE PROXIMATE BREAST IMPLANT | February 2025 | September 2025 | Allow | 7 | 0 | 0 | Yes | No |
| 18951938 | BIOCATALYSTS FOR ORGANIC SYNTHESIS | November 2024 | January 2026 | Allow | 14 | 2 | 1 | No | No |
| 18763218 | METHODS FOR QUANTIFYING STARCH AND CELLULOSE IN CORN SAMPLES | July 2024 | November 2025 | Allow | 16 | 1 | 1 | Yes | No |
| 18424597 | CELL POPULATIONS OF CD31-POSITIVE, CD45-NEGATIVE, CD200-POSITIVE MAMMALIAN CELLS AND USE THEREOF | January 2024 | February 2025 | Allow | 12 | 0 | 0 | No | No |
| 18390083 | APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS | December 2023 | March 2025 | Allow | 15 | 2 | 1 | Yes | No |
| 18500708 | ETHYLENE OXIDE ABSORPTION LAYER FOR ANALYTE SENSING AND METHOD | November 2023 | July 2025 | Allow | 20 | 2 | 0 | No | No |
| 18494167 | Methods and Compositions for Improving Quality of Life and Increasing Activity in Aging and Chronically Ill Mammals | October 2023 | October 2025 | Allow | 24 | 2 | 0 | Yes | No |
| 18480790 | ENZYME MEDIATOR FUNCTIONALIZED POLYMERS FOR USE WITH ANALYTE SENSORS | October 2023 | September 2025 | Allow | 24 | 0 | 1 | Yes | No |
| 18477766 | MICROBIAL COMPOSITIONS FOR FOWL HEALTH AND PERFORMANCE | September 2023 | July 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18470720 | TREATMENT OF CONNECTIVE TISSUE INJURIES | September 2023 | June 2024 | Allow | 9 | 1 | 0 | Yes | No |
| 18369464 | HIGH PURITY STARCH STREAM METHODS AND SYSTEMS | September 2023 | December 2025 | Allow | 27 | 2 | 1 | Yes | No |
| 18343187 | SELECTION AND USE OF UMBILICAL CORD CELL FRACTIONS SUITABLE FOR TRANSPLANTATION | June 2023 | August 2025 | Abandon | 26 | 0 | 1 | No | No |
| 18333957 | MICROBIOLOGICAL GROWTH MEDIA AND METHODS OF USING THE SAME | June 2023 | March 2025 | Allow | 21 | 1 | 0 | No | No |
| 18031880 | METHOD FOR IMPROVING EFFICIENCY OF ANAEROBIC FERMENTATION IN MEDIUM TEMPERATURE-HIGH TEMPERATURE TRANSITION ZONE | April 2023 | June 2024 | Allow | 14 | 2 | 0 | Yes | No |
| 18134077 | NATIVE CELL DERIVED VESICLES CONTAINING TUMOR SUPPRESSOR PROTEINS FOR THERAPY | April 2023 | March 2026 | Allow | 35 | 0 | 1 | Yes | No |
| 18191791 | GENERATION OF TUMOR IMMUNITY USING ASTROCYTES AND ASTROCYTE-DENDRITIC CELL COMBINATIONS | March 2023 | February 2026 | Allow | 35 | 1 | 0 | No | No |
| 18245753 | METHODS FOR INCREASING PRODUCTIVITY OF THERAPEUTIC PROTEINS | March 2023 | October 2025 | Allow | 31 | 0 | 1 | No | No |
| 18164525 | CMOS-BASED LOW-POWER, LOW-NOISE POTENTIOSTAT CIRCUIT AND ITS INTEGRATION WITH AN ENFM-BASED GLUCOSE SENSOR | February 2023 | December 2025 | Allow | 34 | 1 | 0 | No | No |
| 18155790 | COMPOSITION FOR PREVENTING, TREATING, OR ALLEVIATING VIRAL INFECTION DISEASES OR RESPIRATORY DISEASES COMPRISING VESICLE DERIVED FROM LACTOBACILLUS PARACASEI | January 2023 | October 2024 | Allow | 21 | 0 | 0 | No | No |
| 18080371 | FEED SUPPLEMENT BOLUS WITH ACTIVE YEAST | December 2022 | January 2026 | Abandon | 37 | 1 | 0 | No | No |
| 17981448 | Application of TREM2hi macrophages in the preparation of drugs for the treatment of cardiac dysfunction | November 2022 | November 2025 | Allow | 36 | 0 | 0 | Yes | No |
| 17981384 | Synthetic Microbial Community for Phyllosphere Application | November 2022 | May 2025 | Allow | 31 | 1 | 1 | No | No |
| 17997346 | BINDING AGENTS AND USES THEREOF FOR CENTRAL NERVOUS SYSTEM DELIVERY | October 2022 | December 2025 | Allow | 38 | 0 | 1 | Yes | No |
| 17920440 | SYSTEM, DEVICE, AND METHOD FOR SINGLE-CELL ENCAPSULATION AND CULTURE | October 2022 | December 2025 | Allow | 38 | 1 | 1 | Yes | No |
| 18048759 | CIRCULATING TUMOR CELL DIAGNOSTICS FOR LUNG CANCER | October 2022 | May 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17967469 | REGENERATIVE NONSTEROIDAL ANTI-INFLAMMATORY COMPOSITIONS, METHODS OF PRODUCTION, AND METHODS OF USE THEREOF | October 2022 | February 2026 | Abandon | 40 | 0 | 1 | No | No |
| 17964715 | Organotypic Brain Slice Culture Model of Human Neuroinflammatory Environment Associated with Neurodegeneration | October 2022 | January 2026 | Abandon | 39 | 0 | 1 | No | No |
| 17995708 | UNIT FOR ANGIOGENESIS PROMOTION AND/OR NERVE REGENERATION | October 2022 | January 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17912730 | COMPOSITIONS AND TREATMENTS FOR ISCHEMIC INJURIES | September 2022 | December 2025 | Allow | 39 | 1 | 1 | No | No |
| 17906612 | BACILLUS VELEZENSIS, CULTURE METHOD THEREFOR AND APPLICATION THEREOF | September 2022 | February 2024 | Allow | 17 | 2 | 0 | No | No |
| 17946106 | METHOD FOR PRODUCING CELL-CONTAINING EXTRACELLULAR MATRIX, CELL CULTURE METHOD, DEVICE FOR PRODUCING CELL-CONTAINING EXTRACELLULAR MATRIX AND CONTROL PROGRAM | September 2022 | December 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17912458 | USE OF MITOCHONDRIA TO TREAT AND/OR PREVENT TENDON INJURY OR ITS RELATED DISEASE | September 2022 | January 2026 | Allow | 41 | 2 | 0 | Yes | No |
| 17900862 | BIFIDOBACTERIUM LACTIS STRAIN FOR PREVENTING OR TREATING COLITIS AND METHOD FOR PREVENTING OR ALLEVIATING COLITIS | August 2022 | February 2024 | Allow | 17 | 3 | 0 | No | No |
| 17802108 | Use Of Radiation To Predispose Platelet Activation | August 2022 | January 2026 | Abandon | 40 | 0 | 1 | No | No |
| 17792396 | USE OF RHODOCOCCUS RUBER CELL WALL SKELETON IN REGENERATIVE MEDICINE | July 2022 | February 2025 | Allow | 31 | 0 | 0 | Yes | No |
| 17811542 | NOVEL LACTOBACILLUS PLANTARUM STRAIN, POLYSACCHARIDES DERIVED FROM STRAIN, AND USE THEREOF | July 2022 | April 2023 | Allow | 9 | 1 | 1 | Yes | No |
| 17852940 | EFFICIENT MULTI-DIMENSIONAL CARBON SOURCE AND METHOD FOR PREPARING THE SAME | June 2022 | December 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17789228 | Method For Producing Citric Acid by Degrading Roughages with the Rumen Fungus-methanogen Co-culture from Qinghai Yaks | June 2022 | April 2024 | Allow | 22 | 1 | 0 | Yes | No |
| 17757387 | INHIBITION OF TNF-ALPHA BY FIBROBLASTS AND FIBROBLAST EXOSOMES | June 2022 | November 2025 | Allow | 41 | 0 | 1 | Yes | No |
| 17781490 | METHOD FOR PREPARING GALACTO-OLIGOSACHARIDES FROM LACTULOSE | June 2022 | May 2025 | Allow | 35 | 0 | 0 | Yes | No |
| 17733887 | METHODS OF CROP RESIDUAL MANAGEMENT WITH MICROALGAE COMPOSITIONS | April 2022 | April 2025 | Allow | 36 | 0 | 0 | Yes | No |
| 17772620 | PAENIBACILLUS ISOLATES AND USES THEREOF | April 2022 | September 2025 | Allow | 41 | 1 | 1 | No | No |
| 17728833 | SEMI-CONTINUOUS CULTURE METHODS | April 2022 | July 2025 | Allow | 38 | 1 | 0 | Yes | No |
| 17767843 | ENGINEERED TRIMERIC CD70 PROTEINS AND USES THEREOF | April 2022 | March 2025 | Allow | 35 | 0 | 1 | Yes | No |
| 17658406 | PROCESS FOR PURIFICATION OF MALONIC ACID FROM FERMENTATION BROTH | April 2022 | February 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17712326 | CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE | April 2022 | June 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17655825 | METHOD FOR FACILITATING MATURATION OF THE MAMMALIAN IMMUNE SYSTEM | March 2022 | January 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17699910 | HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE | March 2022 | May 2025 | Allow | 38 | 2 | 0 | No | No |
| 17641431 | SPLIT INTEIN AND PREPARATION METHOD FOR RECOMBINANT POLYPEPTIDE USING THE SAME | March 2022 | October 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17653209 | TREATMENT OF CONNECTIVE TISSUE INJURIES | March 2022 | July 2025 | Allow | 41 | 1 | 0 | Yes | No |
| 17684258 | COMPOSTING SYSTEM AND METHOD | March 2022 | September 2025 | Abandon | 43 | 1 | 1 | No | No |
| 17673914 | HYDROTHERMAL-MECHANICAL CONVERSION OF LIGNOCELLULOSIC BIOMASS TO ETHANOL OR OTHER FERMENTATION PRODUCTS | February 2022 | September 2024 | Allow | 31 | 1 | 0 | No | No |
| 17633950 | PREPARATION METHOD FOR SILK FIBROIN NERVE GRAFT FUSED WITH NT3 | February 2022 | August 2025 | Allow | 42 | 0 | 0 | No | No |
| 17586347 | COMPOSITION FOR PREVENTING, TREATING, OR ALLEVIATING VIRAL INFECTION DISEASES OR RESPIRATORY DISEASES COMPRISING VESICLE DERIVED FROM LACTOBACILLUS PARACASEI | January 2022 | October 2022 | Allow | 9 | 1 | 1 | Yes | No |
| 17571209 | MICROBIOMES AND METHODS FOR PRODUCING MEDIUM-CHAIN FATTY ACIDS FROM ORGANIC SUBSTRATES | January 2022 | February 2025 | Allow | 37 | 1 | 1 | No | No |
| 17625220 | MODIFIED ESCHERICHIA COLI STRAIN NISSLE AND TREATMENT OF GASTROINTESTINAL DISORDER | January 2022 | February 2024 | Allow | 25 | 0 | 1 | No | No |
| 17646819 | Autocatalytic Relay Loop Signal Amplification Mechanism and Applications Thereof | January 2022 | March 2024 | Allow | 27 | 1 | 1 | Yes | No |
| 17618949 | IMPROVEMENTS IN OR RELATING TO NICKING ENZYMES | December 2021 | July 2025 | Allow | 43 | 0 | 1 | Yes | No |
| 17547863 | LARGE SCALE PRODUCTION OF RETINAL PIGMENT EPITHELIAL CELLS | December 2021 | April 2023 | Allow | 16 | 2 | 1 | No | No |
| 17617332 | SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL DNA VECTORS | December 2021 | October 2025 | Allow | 47 | 1 | 1 | No | No |
| 17456215 | SYSTEM AND METHOD OF NUCLEIC ACID EXTRACTION | November 2021 | December 2025 | Abandon | 49 | 1 | 1 | No | No |
| 17455971 | METHOD FOR MANUFACTURING DEVICE, DEVICE, AND KIT | November 2021 | May 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17523064 | Biocontrol Strain YW-1 and Preparation Method and Application of Biocontrol Agent Thereof | November 2021 | August 2023 | Allow | 21 | 1 | 0 | No | No |
| 17501753 | LARGE SCALE CELL CULTURE SYSTEM FOR MAKING MEAT AND ASSOCIATED PRODUCTS | October 2021 | June 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17497798 | DEVICE FOR ANALYSIS OF CELLULAR MOTILITY | October 2021 | July 2025 | Allow | 46 | 1 | 0 | Yes | No |
| 17488454 | DECELLULARISED CELL WALL STRUCTURES FROM FUNGUS AND USE THEREOF AS SCAFFOLD MATERIALS | September 2021 | July 2024 | Allow | 33 | 1 | 0 | Yes | No |
| 17472366 | TREATMENT OF CONNECTIVE TISSUE INJURIES | September 2021 | February 2022 | Allow | 5 | 1 | 1 | No | No |
| 17409193 | CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN | August 2021 | November 2024 | Allow | 39 | 0 | 0 | No | No |
| 17406928 | TRANSGLUTAMINASE NANOFLOWERS | August 2021 | August 2024 | Allow | 36 | 0 | 1 | Yes | No |
| 17431708 | PLANT GROWTH-PROMOTING MICROBES, COMPOSITIONS, AND USES THEREOF | August 2021 | May 2025 | Abandon | 45 | 0 | 1 | No | No |
| 17428109 | THERMOSPOROTHRIX HAZAKENSIS-DERIVED ANTIBACTERIALLY ACTIVE SUBSTANCE | August 2021 | November 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17378845 | ANTIFUNGAL PAENIBACILLUS STRAINS, FUSARICIDIN-TYPE COMPOUNDS, AND THEIR USE | July 2021 | November 2024 | Allow | 40 | 1 | 0 | Yes | No |
| 17359785 | SYSTEM AND METHOD FOR PRODUCING FUEL GRADE ETHANOL FROM CELLULOSIC AND HIGH STARCH COMBINED FEEDSTOCKS | June 2021 | April 2023 | Abandon | 22 | 0 | 1 | No | No |
| 17355093 | PREPARATION OF RETINAL PIGMENT EPITHELIUM CELLS | June 2021 | September 2024 | Allow | 39 | 1 | 0 | No | No |
| 17304185 | CULTURE DEVICE AND METHODS FOR ENUMERATING MOLD COLONIES | June 2021 | September 2024 | Allow | 39 | 0 | 0 | Yes | No |
| 17338285 | TESTER PAPER AND METHODS OF USE THEREOF FOR DETECTING A BACTERIAL INFECTION | June 2021 | September 2024 | Allow | 40 | 0 | 1 | No | No |
| 17314190 | GROWTH PERFORMANCE IMPROVEMENTS IN PASTURE AND FEEDLOT SYSTEMS | May 2021 | July 2024 | Allow | 38 | 2 | 0 | No | No |
| 17228058 | FREEZING AND ARCHIVING CELLS ON A MICROFLUIDIC DEVICE | April 2021 | May 2024 | Allow | 37 | 0 | 0 | No | No |
| 17212376 | AUTOMATED TISSUE ENGINEERING SYSTEM | March 2021 | February 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17275164 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | March 2021 | November 2025 | Allow | 56 | 1 | 2 | Yes | No |
| 17189417 | SYSTEM AND PROCESS FOR ADDING PRE-FERMENTATION SEPARATED NON-FERMENTABLES TO A POST-FERMENTATION STREAM | March 2021 | April 2025 | Allow | 49 | 1 | 0 | Yes | No |
| 17270516 | NOVEL CUTIBACTERIUM AVIDUM STRAIN, AND COMPOSITION FOR PREVENTING OR TREATING ATOPIC DERMATITIS, COMPRISING STRAIN OR CULTURED PRODUCT THEREOF | February 2021 | September 2022 | Allow | 18 | 1 | 0 | No | No |
| 17182039 | Method for Using Electrochemical Bioreactor Module with Recovery of Cofactor | February 2021 | January 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17181115 | METHODS FOR QUANTIFYING STARCH CELLULOSE IN CORN SAMPLES | February 2021 | March 2024 | Allow | 37 | 1 | 0 | No | No |
| 17174102 | ECONOMIC SUGAR STREAM, PROCESSES AND SYSTEMS OF PRODUCING SAME | February 2021 | May 2024 | Allow | 39 | 1 | 1 | Yes | No |
| 17166605 | METHODS OF TREATING CONGENITAL HEMOPHILIA WITH ANTI-FIBRINOLYTIC LOADED PLATELETS | February 2021 | January 2025 | Abandon | 48 | 1 | 0 | No | No |
| 17265309 | METAL MATERIAL, METHOD OF CONTROLLING RESPONSE OF FERMENTATIVE MICROORGANISM, AND METHOD OF PRODUCING FERMENTED FOOD PRODUCT | February 2021 | August 2024 | Abandon | 43 | 1 | 1 | No | No |
| 17265097 | Exopolysaccharide from Rhodopseudomonas palustris and Method for Preparing and Use Thereof | February 2021 | May 2022 | Allow | 16 | 1 | 0 | Yes | No |
| 17151458 | PREPARATION OF HUMAN PLATELET LYSATE (HPL) FROM REFRIGERATED WHOLE BLOOD PLATELETS | January 2021 | November 2025 | Allow | 58 | 3 | 0 | Yes | No |
| 17144739 | TISSUE-BASED COMPOSITIONS AND METHODS OF USE THEREOF | January 2021 | November 2023 | Allow | 34 | 1 | 0 | No | No |
| 17258510 | AKKERMANSIA MUCINIPHILA EB-AMDK27 STRAIN AND USE THEREOF | January 2021 | July 2022 | Allow | 18 | 1 | 0 | No | No |
| 17255201 | MODIFIED T CELLS AND USES THEREOF | December 2020 | September 2024 | Allow | 45 | 1 | 1 | No | No |
| 17116629 | SYSTEM FOR THE PRODUCTION OF METHANE FROM CO2 | December 2020 | April 2025 | Allow | 52 | 2 | 1 | No | No |
| 17114827 | COMPOSITION FOR STRENGTHENING SKIN BARRIER, MOISTURIZING SKIN OR ANTI-AGING | December 2020 | July 2023 | Allow | 31 | 2 | 0 | Yes | No |
| 17114152 | ORAL COMPOSITIONS | December 2020 | June 2024 | Allow | 43 | 1 | 1 | Yes | No |
| 15734280 | METHOD FOR CONVERTING CO2 BY MEANS OF BIOLOGICAL REDUCTION | December 2020 | September 2022 | Allow | 21 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner UNDERDAHL, THANE E.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 21.4% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner UNDERDAHL, THANE E works in Art Unit 1699 and has examined 235 patent applications in our dataset. With an allowance rate of 77.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.
Examiner UNDERDAHL, THANE E's allowance rate of 77.4% places them in the 44% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by UNDERDAHL, THANE E receive 1.71 office actions before reaching final disposition. This places the examiner in the 36% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by UNDERDAHL, THANE E is 38 months. This places the examiner in the 29% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +31.7% benefit to allowance rate for applications examined by UNDERDAHL, THANE E. This interview benefit is in the 79% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 32.4% of applications are subsequently allowed. This success rate is in the 68% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 28.1% of cases where such amendments are filed. This entry rate is in the 40% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 2% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 88% percentile among all examiners. Of these withdrawals, 71.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 53.8% are granted (fully or in part). This grant rate is in the 55% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.4% of allowed cases (in the 59% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 4% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.